Vaccine Composition Formulated with a Novel Lactobacillus-Derived Exopolysaccharides Adjuvant Provided High Protection against Staphylococcus aureus

A vaccine that effectively targets methicillin-resistant Staphylococcus aureus (MRSA) is urgently needed, and has been the focus of studies by numerous research groups, but with limited success to date. Recently, our team found that exopolysaccharides derived from probiotic Lactobacillus casei strai...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Haochi, Pan, Na, Ma, Cheng, Liu, Bohui, Xiu, Lei, Tong, He, Sheng, Shouxin, Liang, Yanchen, Li, Haotian, Ma, Fangfei, Bao, Xuemei, Hu, Wei, Wang, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310297/
https://www.ncbi.nlm.nih.gov/pubmed/34358191
http://dx.doi.org/10.3390/vaccines9070775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310297/
https://www.ncbi.nlm.nih.gov/pubmed/34358191
http://dx.doi.org/10.3390/vaccines9070775

Ejemplares similares